Associations of bisphenol and phthalate exposure and anti-Müllerian hormone levels in women of reproductive age

被引:0
|
作者
Blaauwendraad, Sophia M. [1 ,2 ]
Dykgraaf, Ramon H. M. [3 ]
Gaillard, Romy [1 ,2 ]
Liu, Mengling [4 ,5 ]
Laven, Joop S. [3 ]
Jaddoe, Vincent W. V. [1 ,2 ]
Trasande, Leonardo [4 ,5 ]
机构
[1] Univ Med Ctr, Erasmus Med Ctr MC, Generat Study Grp R, Rotterdam, Netherlands
[2] Univ Med Ctr, Dept Pediat, Erasmus MC, Rotterdam, Netherlands
[3] Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands
[4] NYU, Dept Environm Med, Sch Med, New York, NY USA
[5] NYU, Coll Global Publ Hlth, New York, NY USA
关键词
Bisphenols; Phthalates; anti-M & uuml; llerian hormone; Ovarian reserve; ANTI-MULLERIAN HORMONE; OVARIAN RESERVE; METABOLITES; COHORT;
D O I
10.1016/j.eclinm.2024.102734
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In women, exposure to endocrine disrupting chemicals might accelerate the depletion of the ovarian reserve and might be associated with accelerative reproductive aging and fertility. We examined the longitudinal associations of exposure to bisphenols and phthalates with anti-M & uuml;llerian hormone concentrations. Methods Pregnant women of 18 years or older that resided in Rotterdam between 2002 and 2006 were eligible for participation in this longitudinal prospective cohort study. We measured urinary bisphenol and phthalate concentration at three time-points in pregnancy among 1405 women, of whom 1322 women had serum Anti-M & uuml;llerian Hormone (AMH) measurements 6 and/or 9 years postpartum. We performed linear regression models to assess the association of urinary bisphenol and phthalate metabolites with AMH after 6 and 9 years, and linear mixedeffect model to assess the association with AMH over time. Models were adjusted for sociodemographic and lifestyle factors. Findings In our multivariable linear regression models we observed associations of higher urinary pregnancyaveraged mono-isobutyl phthalate (mIBP), mono-(2-ethyl-5-oxohexyl) phthalate (mEOHP), and monobenzyl phthalate (mBzBP) with lower serum AMH after both 6 and 9 years. However, these associations did not remain after adjustment for multiple testing. No signi fi cant associations of bisphenol A with AMH were present in our study sample. In our linear mixed-effects models, higher mIBP, mono-(2-ethyl-5-hydroxyhexyl) phthalate (mEHHP), mEOHP, and mBzBP were associated with lower overall AMH levels (differences - 0.07 (95% CI - 0.13, - 0.02), - 0.09 ( - 0.15, - 0.02), - 0.08 (95% CI - 0.14, - 0.02), and - 0.08 ( - 0.13, - 0.03) mu g/L per doubling in mIBP, mEHHP, mEOHP, and mBzBP respectively) (all False Discovery Rate adjusted p-values < 0.05). Interpretation We identify decreases in indices of ovarian reserve in relationship to prenatal phthalate exposures. Studies are needed replicating our results among large multi-ethnic non-pregnant populations and assessing transgenerational effects of exposure on ovarian reserve. Copyright (c) 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:10
相关论文
共 50 条
  • [11] Erratum to: Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment
    B. Meczekalski
    A. Czyzyk
    M. Kunicki
    A. Podfigurna-Stopa
    L. Plociennik
    G. Jakiel
    M. Maciejewska-Jeske
    K. Lukaszuk
    Journal of Endocrinological Investigation, 2016, 39 : 1267 - 1267
  • [12] Anti-Müllerian hormone levels and risk of type 2 diabetes in women
    Renée M. G. Verdiesen
    N. Charlotte Onland-Moret
    Carla H. van Gils
    Rebecca K. Stellato
    Annemieke M. W. Spijkerman
    H. Susan J. Picavet
    Frank J. M. Broekmans
    W. M. Monique Verschuren
    Yvonne T. van der Schouw
    Diabetologia, 2021, 64 : 375 - 384
  • [13] Assessment of anti-Müllerian hormone levels as a reproductive indicator in Japanese Black cattle
    Koyama, Takeshi
    Suzuki, Hiromi
    Shimizu, Miki
    Mizuno, Riuru
    Ishigami, Ayaha
    Kamidate, Nobuyuki
    Otani, Yoshihisa
    Okubo, Michiko
    Souma, Kousaku
    Hirayama, Hiroki
    JOURNAL OF REPRODUCTION AND DEVELOPMENT, 2024, 70 (06): : 389 - 395
  • [14] Genetic Prediction of Osteoporosis by Anti-Müllerian Hormone Levels and Reproductive Factors in Women: A Mendelian Randomization Study
    Li, Yuan
    Lai, Jinquan
    Wu, Wenbo
    Ling, Shuyi
    Dai, Yuqing
    Zhong, Zhisheng
    Chen, Xiaodong
    Zheng, Yuehui
    CALCIFIED TISSUE INTERNATIONAL, 2024, 115 (01) : 41 - 52
  • [15] Demographic, lifestyle, and reproductive determinants of serum anti-Müllerian hormone levels in adult women of reproductive age in Ilorin, North-Central Nigeria
    Oyinkansola Islamiyat Lawal
    Jameelu-deen Omokunmi Yusuff
    Middle East Fertility Society Journal, 26
  • [16] Elevated serum thyroid-stimulating hormone is associated with decreased anti-Müllerian hormone in infertile women of reproductive age
    Keiji Kuroda
    Toyoyoshi Uchida
    Saki Nagai
    Rie Ozaki
    Takashi Yamaguchi
    Yuichi Sato
    Jan J. Brosens
    Satoru Takeda
    Journal of Assisted Reproduction and Genetics, 2015, 32 : 243 - 247
  • [17] Anti-Müllerian Hormone Concentrations in Women of Different Reproductive Age and the Chances of IVF Outcome: A Paradigm Shift is needed
    Wyroba, Jakub
    Kochan, Joanna
    Kelley, Liam
    Iqbal, Sharif
    Kordowitzki, Pawel
    AGING AND DISEASE, 2025,
  • [18] Anti-Müllerian hormone levels in relation to ovarian structures, season and age in Lipizzaner broodmares
    Angyal, Eszter
    Vincze, Boglarka
    Somoskoi, Bence
    Sos-Koroknai, Viktoria
    Balogh, Peter
    Danko, Gabriella Novotnine
    Cseh, Sandor
    Kutvolgyi, Gabriella
    ACTA VETERINARIA HUNGARICA, 2025,
  • [19] The effect of radioactive iodine therapy on anti-Müllerian hormone changes in women with thyroid cancer at reproductive age: a prospective study
    Ali Hosseini
    Zohreh Lavasani
    Middle East Fertility Society Journal, 28
  • [20] Variability of anti-Müllerian hormone levels following gonadotoxic therapy
    von Horn K.
    Strowitzki T.
    Germeyer A.
    Gynäkologische Endokrinologie, 2018, 16 (1) : 61 - 63